SCIENCE appears to have finally found the elusive cure for baldness. Proscar, a drug manufactured by Merck & Co to treat enlarged prostate glands, has an interesting side-effect: in low doses, it increases hair growth.
In clinical trials carried out on 200 young men at an early stage of baldness, low doses of the drug produced a significant increase in hair numbers compared with patients taking a placebo, according to Merck research chief Edward M Scolnick. The dose is much lower than that used to treat enlarged prostates.
Merck officials claim low doses of the drug are safe, but higher doses could cause some side effects. Merck plans to market the drug as a baldness treatment once further studies to prove its effectiveness are completed.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.